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Background: Miniaturised bioassays permit diagnostic testing near 
the patient, and the results can be recorded digitally using 
inexpensive cameras including smartphone and mobile phone 
cameras. Although digital cameras are now inexpensive and portable, 
the minimum performance required for microfluidic diagnostic 
bioassays has not been defined. We present a systematic comparison 
of a wide range of different digital cameras for capturing and 
measuring results of microfluidic bioassays and describe a framework 
to specify performance requirements to quantify immunoassays. 
Methods: A set of 200 µm diameter microchannels was filled with a 
range of concentrations of dyes used in colorimetric and fluorometric 
enzyme immunoassays. These were imaged in parallel using cameras 
of varying cost and performance ranging from <£30 to >£500. 
Results: Higher resolution imaging allowed larger numbers of 
microdevices to be resolved and analysed in a single image. In 
contrast, low quality cameras were still able to quantify results but for 
fewer samples. In some cases, an additional macro lens was added to 
focus closely. If image resolution was sufficient to identify individual 
microfluidic channels as separate lines, all cameras were able to 
quantify a similar range of concentrations of both colorimetric and 
fluorometric dyes. However, the mid-range cameras performed 
better, with the lowest cost cameras only allowing one or two samples 
to be quantified per image. Consistent with these findings, we 
demonstrate that quantitation (to determine endpoint titre) of 
antibodies against dengue and severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) viruses is possible using a wide range of 
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digital imaging devices including the mid-range smartphone iPhone 
6S and a budget Android smartphone costing <£50. 
Conclusions: In conclusion, while more expensive and higher quality 
cameras allow larger numbers of devices to be simultaneously 
imaged, even the lowest resolution and cheapest cameras were 
sufficient to record and quantify immunoassay results.
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Introduction
The use of digital cameras in consumer devices, such as 
smartphones, to record the results of miniaturised bioassays, 
offers many potential advantages in clinical diagnostics. 
Smartphones can digitally record, interpret and quantify many 
measurements that have previously relied on a laboratory 
instrument to analyse, or needed a human operator to interpret 
lines or colour change by eye and then manually record 
results. A wide spectrum of devices and bioassays have been 
read using smartphones1, including pH in clinical samples2 
immunoassays3,4, nucleic acid detection5,6, microbiology7,8, and 
paper devices including urine analysis dipsticks9 or cholesterol 
test strips10. Smartphones offer a combination of three features 
in an accessible package: high performance camera, on-board 
computing power, and networking. Firstly, optimised miniatur-
ised optics combined with high-performance complementary 
metal oxide semiconductor (CMOS) image sensors deliver 
increasingly high-performance digital cameras. Secondly, con-
stantly advancing processors deliver local fast and powerful 
computing capacity, plus onboard random-access memory 
(RAM) and secure digital (SD) card data storage allow image 
acquisition, storage, processing and analysis. Thirdly, mobile 
network bandwidth and expansion of wireless networking 
permits integration to connected health systems and – if 
handset computing power is insufficient- cloud-based analysis 
of results. The latter two features can also be used without 
the camera to power external sensor modules11. Bioassays read 
by smartphone can aid diagnosis either as stand-alone point- 
of-care clinical measurement12, or results can be combined with 
other clinical data where smartphones have been explored for 
providing clinical guidance in the field13,14.
The large consumer markets and massive sales volumes have 
driven up hardware performance and cut optoelectronic 
component price. However, the latest high-end products with 
highest hardware performance and most handset features 
comes at increased price, with cost of many high-end smart-
phone handsets exceeding £1000. Alternative, lower price and 
performance options have followed. Two classes of low-budget 
mobile phone handset have emerged. Firstly, in many regions 
of the world (e.g. India, many African states) mobile phones 
without the networking and microprocessor power of smart-
phones, termed “feature phones” have been the most widely 
owned handsets15. These offer longer battery life and are better 
suited to users and regions where network capacity is limited 
and communication by phone/SMS remains the most important 
driver for mobile phone ownership. Secondly, budget smart-
phones have proliferated, especially those with android operating 
system, with reduced features (e.g. older operating systems) and 
less highly specified hardware (less memory, simpler screen, 
lower resolution camera, cheap casework). Touchscreen, fully 
networked android handsets are available under £50. Whilst 
many feature phones do have cameras, the limited screen size 
and memory ensures these are hard to use and they are typically 
equipped with very simple low-resolution optoelectronics.
Consumer products such as smartphones can be hard to adopt 
into diagnostics because their closed and rapidly changing 
software, and variable hardware specification, is not compatible 
with tightly regulated and standardised requirements for 
regulatory approved diagnostics. An alternative to using 
consumer products is to exploit the underlying hardware 
(e.g. optoelectronic components) to build bespoke, regulatory 
approved, camera-based readers/analysers. The CMOS sensors 
and lenses found within smartphones are increasingly available 
as camera modules. The most readily available are bundled 
with single-board computers such as the Raspberry Pi, or with 
microcontrollers. Industrial use of digital cameras for example 
in manufacturing for machine vision has likewise grown 
accelerated by the fall in cost of cameras and network/process-
ing power16. The cameras used in industrial applications 
have one major advantage over consumer products, which 
is greater robustness and manufacturing specifications for 
longer-term use coupled with more software control, compared 
to the short product life for consumer products where profit is 
driven by frequent replacements. Furthermore, smartphone 
camera software optimises images for consumer preference- not 
diagnostic accuracy. However, this comes at a cost, with machine 
vision cameras typically costing far more for equivalent sensors.
As many studies17–19 have reported proof-of-concept demonstrat-
ing that smartphone imaging can be used to read microfluidic 
assays a systematic comparison of different digital camera 
hardware is warranted to understand the key parameters for 
digital imaging of bioassays. We developed a simple and low- 
cost microfluidic platform that exploits the optical transparency 
of melt-extruded fluoropolymer microcapillary film (MCF). 
We previously showed both smartphone and consumer digital 
cameras, as well as the Raspberry Pi camera, can quantify 
immunoassay and analytical microbiology assays within 
affordable microfluidic devices made from MCF3,20–24. The low 
cost of the devices and the optical transparency achieved through 
refractive index matching makes this simple platform ideally 
suited to systematic comparison of imaging performance.
Here, we compared the analytical performance of a range of 
digital cameras and tested if lower cost feature phones and 
budget smartphone handsets were capable of recording colori-
metric and fluorometric dyes within microfluidic devices. Using 
MCF as an example of microfluidic bioassays, we systemati-
cally compared the optical sensitivity, resolution and therefore 
analytical performance of these low-cost units against higher-
specified smartphones and higher performance digital cameras. 
We also compared these consumer products with an industrial 
camera module developed for machine vision applications and a 
Raspberry Pi camera. Finally, we assessed if these digital 
cameras could measure simulated antibody responses against 
two viral infections of global health significance- dengue fever 
and coronavirus disease 2019 (COVID-19).
Methods
Experimental approach
We established a simple imaging rig to systematically determine 
the performance of a range of digital cameras for imaging 
colorimetric and fluorometric assays within microfluidic devices 
(Figure 1A). To allow us to control the microfluidic device 
characteristics and directly compare camera performances, we 
used colorimetric and fluorescent dye solutions- rather than 
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Figure 1. Experimental setup to systematically compare the digital image quantitation of microfluidic bioassays by different 
cameras and smartphones. A) Microcapillary film strips were used as examples of microfluidic devices capable of performing immunoassays. 
Sets of colorimetric or fluorescent dye solutions were loaded in a panel of strips and imaged either on a white light background for 
colorimetric (absorbance) measurement, or with blue light emitting diode (LED) excitation imaged through an amber emission filter for 
fluorescent. The absorbance or fluorescence intensity for each capillary was analysed for the appropriate red-green-blue (RGB) colour 
channel using ImageJ as indicated. B) Comparison of image quality for mid-range smartphone vs the cheapest camera, illustrating how 
lower quality images cannot resolve individual capillaries but variation in intensity is still clear. C) Illustration of systematic comparison of 
cameras for imaging microfluidic bioassays. D) effect of camera settings on fluorescence detection, showing that varying shutter speed can 
dramatically alter dynamic range of fluorophore measurement. The same set of serial fluorescein dilutions were imaged with the indicated 
range of shutter speeds. Mean fluorescence intensity for 20 replicate capillaries in duplicate microcapillary film (MCF) test strips were 
plotted, with error bars indicating standard deviation.
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full immunoassays where substrate conversion is dynamic and 
target dye concentrations are uncontrolled. Di-amino phenazine 
(DAP) is the yellow dye product produced by the horseradish 
peroxidase enzyme, commonly used in colorimetric immu-
noassays, acting upon the o-Phenylenediamine dihydrochloride 
substrate (OPD) substrate often used in colorimetric immu-
noassays. Fluorescein is used both directly for fluorescent 
detection and also as the product of alkaline phosphatase 
conversion of the substrate fluorescein di-phosphate (FDP) and 
is spectrally similar to other alkaline phosphatase substrates 
such as Attophos™. Following this systematic comparison using 
dyes, selected cameras were used to image full immunoassays that 
simulated the measurement of antibodies against important viral 
antigens, to confirm the findings could be applied to clinically 
relevant diagnostics bioassays. For all the cameras but the 
G:Box, the images were taken at about 10cm from the subject 
and using a digital setting of 1 (equivalent to no zoom). The 
distance of the camera to the sample was recorded and this 
working distance shown for different cameras below alongside 
example images. Automatic settings were used for the Raspberry 
Pi 3B+, the toy camera, the Alba Phone and the iPhone 6S. 
Manual settings were used to take images with the Powershot 
S120, with a fixed ISO of 3200 and variable F-Stop and exposure.
Target microfluidic devices for fluorometric and colorimetric 
signal detection. Whilst the characteristics of the microchan-
nels within MCF are typical of many microfluidic devices, 
with assay channels of 200 µm internal diameter, they have the 
advantage of low cost allowing large numbers of devices to 
be filled with differing dye concentrations and simultaneously 
imaged. They have some unique features including a cylindrical 
cross-section that results in an elliptical intensity plot when 
projected onto a flat image, and refractive index matching 
between fluoropolymer device and water, avoiding distortion 
at the interface between aqueous sample and microdevice. 
Previous studies have shown these permit a wide range of 
bioassays to be conducted including immunoassays and analytical 
microbiology.
Materials and reagents
The MCF was manufactured by Lamina Dielectrics Ltd 
(Billingshurst, West Sussex, UK) and consisted of an array of 
10 micro-capillaries produced from Teflon®-FEP FEP (fluori-
nated ethylene propylene) (Dow, USA) using a continuous 
melt-extrusion process22,23. The MCF had a width of 4.3mm 
and the mean internal diameter of the microcapillaries was 
206µm. Fluorescein NIST-Traceable Standard (ThermoFisher 
Scientific, UK) was used to assess the cameras/phones 
performance to detect fluorescence and was used as a 
reference for the immunoassays. A stock solution of 100mM 
2,3-Diaminophenazine (DAP) (Sigma, UK) was prepared in 
DMSO. Dilutions of DAP were prepared in SIGMA-FAST 
OPD Buffer (Sigma, UK). DAP was used to assess the cameras/
phones performance to detect colorimetric signals. A 2 mg/mL 
solution of high molecular weight polyvinyl alcohol (PVOH, 
Sigma, UK) in PBS was used to coat the inner surface 
of the micro-capillaries to make them hydrophilic22,23. Human 
negative control serum was bought from Sigma. The blocking 
buffer consisted of Superblock (ThermoFisher Scientific, UK) 
supplemented with 10% foetal bovine serum (Sigma, UK) and 
5% goat serum (Sigma, UK). Positive control antiviral antibodies 
were recombinant human IgG and IgM anti-Flavivirus group 
antigen [D1-4G2-4-15 (4G2)] and human IgM Anti-COVID-19 
& SARS-CoV S glycoprotein [CR3022], obtained from Absolute 
Antibody (Oxford, UK). Anti-human IgG AP and anti-human 
IgM Ap secondary antibodies were purchased from ThermoFisher 
Scientific (UK). For imaging both dengue virus (DENV) and 
SARS-CoV-2 immunoassay strips, AttoPhos® AP Fluorescent 
Substrate System (Promega, UK) was added as the final sub-
strate. Baculovirus expression of viral proteins used Spodoptera 
frugiperda (Sf9) and T.nao38 cells which were maintained in 
EX-CELL 420 medium (Sigma, UK) supplemented with 2% 
fetal bovine serum (Sigma, UK), at 27°C with shaking. Virus 
growth used exclusively Sf9 cells while protein expression used 
T.nao38 cells.
Digital cameras, mobile phones, and imaging devices
For the detection of fluorescent and colorimetric signals, we 
used a wide range of cameras and phones, and professional 
imaging systems (Table 1). We used a DSLR camera EOS 1300D 
with a Canon EF-S 60mm f/2.8 Macro USM Lens (Canon), a 
compact camera Powershot S120 (Canon), a compact waterproof 
and shock-resistant WG4 camera (Ricoh) and a toy camera 
(Sakar). We used smartphones including an iPhones 6S and 4S 
(Apple) and Alba SIM Free 5’’ Android and mobile phones 
such as CAT B30 Phone (Caterpillar) and Alcatel 2008G phone 
(Alcatel) purchased from Argos (UK). The industrial machine 
vision camera USB 3 uEye® XC with a Macro Lens (AE00126; 
IDS Imaging Development Systems, Obersulm, Germany), a 
Raspberry Pi camera module v2 powered by a Raspberry Pi 3 
B+ computer (Raspberry Pi Foundation, UK) and the labora-
tory imaging systems G:BOX (Syngene, UK) and Typhoon 
(Amersham, UK) were also used to detect fluorescent and 
colorimetric signals. Images were taken at a resolution of 
3280x2464 pixels with the Raspberry Pi camera.
To improve the image quality and resolution of some imaging 
systems by allowing closer focussing on the microfluidic 
channels, three type of lenses were used: a simple injection-
moulded plastic magnifying lens, a smartphone clip-on macro 
lens (Amazon, UK) and an industrial machine vision macro lens 
(IDS). These were held directly onto the front of the digital 
camera lens during imaging.
Evaluation of digital imaging performance for 
colorimetric and fluorescent microfluidic assay 
measurement
MCF strips were prepared by firstly giving an internal 
hydrophilic coating with PVOH incubated at room temperature 
(RT) overnight, followed by washing and cutting into individual 
75mm long test strips22. For the colorimetric signal detection, 
a 4mM solution of DAP and 5-fold dilutions in SIGMA-FAST 
OPD Buffer were added to the MCF strips, in duplicate, using 
a 10ml syringe. The images were taken under a white light. The 
absorbance was calculated from the drop in blue light intensities 
measured using ImageJ software25 to plot intensity across the 
microdevice, with the lowest point being taken as maximal 
absorbance value (Figure 1A)3,20,21. For the fluorescent signal 
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detection, 50 uM Fluorescein and 5-fold dilutions in H2O were 
added to the MCF strips, in duplicate, by aspiration with a 10ml 
syringe. The images were taken using a light-emitting diode 
(LED) Transilluminator (IO Rodeo, USA) to provide blue light 
excitation in a dark room with the amber emission filter held 
between the camera and the test strips. The peak fluorescence 
intensity was determined for each microcapillary in the green 
image channel using ImageJ software (Figure 1A).
Image data publication
All image files are published in the associated dataset for this 
paper26, and can be accessed to assess the relative image quality 
of different camera types. The image examples used in the 
figures are constructed from cropped images of individual MCF 
test strips as outlined in the examples shown in Figure 1, but all 
original digital images recorded by the cameras are available 
as underlying data26. A CSV data sheet summarises the image 
file names in this data set of over 170 original image files, and 
this lists the conditions and camera in each image file.
Baculovirus expression and purification of DENV2-E and 
SARS-CoV-2-S1
The sequence of DENV2-E containing domains I and II (EI/II) 
(nt 1 to 891) (accession number NC_001474) was codon 
optimised for Spodoptera frugiperda cells and the honeybee 
melittin signal peptide was added upstream of the sequence. The 
sequence was flanked by 18bps at the 5’ and 3’ ends homolo-
gous to the intended expression vector, pTriEx1.1 before being 
ordered (IDT Europe, Belgium). The 3’ flanking nucle-
otides were also designed to fuse the EI/II ORF in frame to the 
vector’s 6xHis tag encoding sequence. The gene and the 
vector were assembled by recombination using the In-Fusion 
HD Cloning kit (Takara, USA). The assembly reaction was then 
used to transform NovaBlue Singles Competent Cells (EMD 
Millipore, UK). The sequence of SARS-CoV-2 S1 was obtained 
from the cloned full-length S sequence and was cloned into 
the expression vector pTriEx1.1 (EMD Millipore, UK) and 
characterised as described previously27.
Sf9 cells were transfected with the baculovirus expression 
vector FlashBAC Gold (Oxford Expression Technologies, UK) 
and with either DENV2-EI/II or SARS-CoV2-S1 constructs to 
produce recombinant baculovirusesr28. Large-scale protein 
expression was performed by infecting 1L of T.nao38 cells 
with a high titre stock of the recombinant baculovirus and 
incubated for 3-5 days at 27°C. After incubation the superna-
tant containing the secreted protein was harvested, clarified by 
centrifugation at 4,300xg for 20min and filtered through a 
0.45um filter. The clear supernatant was supplemented with 
0.5nM nickel sulphate before being loaded onto the Bio-Scale 
Mini Profinity IMAC Cartridge (Bio-Rad, UK). The elution was 
carried out at a flow rate of 2.5 ml/min with a gradient elution 
of 0.05–0.5M imidazole or 0.05-0.25M imidazole over 60 min 
for DENV2-EI/II or SARS-CoV-2-S1 respectively.
Indirect ELISA for the detection of IgG and IgM
MCF strips were coated with 5 ug/ml of DENV2-EI/II or with 
15 ug/ml SARS-CoV2-S1 and incubated at RT for minimum 
1h. The MCF strips were then coated with 0.1mg/ml PVOH for 
3h at RT before adding blocking buffer. The MCF strips were 
stored overnight at 4°C in blocking buffer. For the DENV2-E 
assays, high (100 µg/ml) and low (5 µg/ml) amount of mono-
clonal IgG or IgM anti-Flavivirus was spiked into human serum 
and compared with human serum with no added anti-Flavivirus 
antibody. For the SARS-CoV-2-S1, a high (50 µg/ml) and low 
(5 µg/ml) amount of monoclonal IgM anti-COVID-19 was 
spiked into human serum and compared with human serum with 
no added anti-COVID-19 antibody. In both cases, seroreactivity 
against the antigen was measured using a conventional end-
point titre protocol, whereby the serum samples were serially 
diluted in blocking buffer. The serum samples were incubated for 
10–20 min, followed by two washed with PBS/T. Then, the 
secondary antibody anti-human IgG or IgM conjugated with 
alkaline phosphatase was added to the strips at a dilution of 
1 µg/ml in blocking buffer. The secondary antibody was incu-
bated for 10–20 min before being washed three times with PBS/T. 
Finally, AttoPhos® AP Fluorescent Substrate System (Promega) 
was added and the fluorescent signal was captured using various 
imaging systems and measured using ImageJ software. For every 
assay, a reference MCF strip containing 2uM of fluorescein was 
added and was used to normalise the fluorescent signals from 
the assays. The relative fluorescent intensity was determined by 
dividing the fluorescent intensity of the assay by the fluorescent 
intensity of the reference.
Results and discussion
A wide range of digital cameras are capable 
of recording and quantifying colorimetric and 
fluorometric microfluidic test results
We established a simple testing rig to systematically compare 
digital images of microfluidic devices with a wide range of 
different cameras of different costs and formats (Figure 1A). 
Overall, we found that all digital cameras tested – even the 
lowest quality and cost – were capable of recording and 
distinguishing signal intensity of microfluidic test results to 
some extent. However, the optics and optoelectronics affected 
sharpness of image and sensitivity of detection for both 
fluorescent and coloured dyes. For example, the iPhone 6S gave 
sharp images with high enough resolution to clearly distinguish 
all capillaries, in contrast to the cheapest toy camera where all 
capillaries were blurred together (Figure 1B). This indistinct 
image is likely a consequence of both poor optics unable to 
resolve the individual capillaries, and limitations of the image 
sensor showing noise and with a pixel size too large to distin-
guish capillaries. In spite of this poor image, a clear concen-
tration-intensity relationship was still very clearly measurable 
for cameras across the range of cost and quality, from the 
digital SLR with largest image sensor and highest quality 
optics, through both mid-range and budget smartphones, to the 
cheapest toy camera (Figure 1C). A concentration-intensity 
relationship could be clearly quantified for both colorimetric 
and fluorescent dyes. This indicates that the most important 
requirement for digital quantitation may be obtaining an image of 
sufficient quality to resolve the microchannels, but that even the 
simplest optical sensors can quantify intensity levels.
Whilst the imaging setup was standardised as far as possible, 
it was clear that camera settings significantly affect signal and 
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made a big impact on both analytical sensitivity and dynamic 
range of detection. It was only possible to control camera 
settings such as exposure, aperture and focus for a subset of 
cameras. By increasing the exposure time (but with fixed aper-
ture and ISO sensitivity), the analytical sensitivity of fluorescence 
detection increased significantly, with lower concentrations 
of fluorescein becoming detectable, alongside an increase in 
background (Figure 1D). At the longest exposure, the highest 
concentrations of fluorescein became saturated, with the 
8-bit image intensity scale providing a limit to the measurable 
dynamic range. For those cameras with automatically controlled 
image settings, we could still compare intensity between devices 
within the same image, but if different devices were imaged 
independently, a reference sample would become essential to nor-
malise sample intensity between images taken at different times3.
Quantitative comparison of camera performance for 
digital imaging of colorimetric microfluidic tests
For each camera tested representative images of colorimetric 
dye filled microcapillary devices on a white light background 
are shown, listed in order of the working distance required to 
image the full set of microcapillary devices (Figure 2A). The 
working distance is also indicated in the figure, and relates to 
the field of view for each camera setup. When imaging this 
full set of samples, all cameras were clearly able to quantify the 
variation in signal intensity between strips to some degree, but 
individual capillaries could only be resolved with a subset of 
cameras. The iPhone 6s, the DSLR Camera EOS1300D and the 
Powershot S120 were the best cameras to image a full of set of 
samples at high resolution. In contrast, the low cost phones 
(CATB30, Alcatel and Alba phones) and the toy camera provided 
poor resolution images which could not be analysed.
For the lower performance cameras with images where 
the resolution was too low to resolve individual capillaries 
multiple devices, we added an additional lens to permit closer 
focus. With the budget smartphone (Alba Phone) the capillaries 
were clearly distinguishable at higher dye concentrations but 
not as sharp as the higher performance cameras, and with the 
cheapest toy camera it was impossible to resolve any different 
capillaries in spite of the clear difference in intensity visible 
between strips of different concentration. Nevertheless, simply 
by adding additional plastic convex lens – sold as “macro 
lens” for addition to small cameras and as clip-on lenses for 
smartphones – it was possible to clearly resolve the individual 
capillaries when only a few strips were imaged (Figure 2B). 
Three additional lenses were compared: the cheapest was an 
injection moulded magnifying lens that allowed focus on 6 test 
strips (around 35mm field of view); whereas both the profes-
sional macro lens for machine vision imaging and the consumer 
smartphone clip-on macro lens allowed focus on 3 test strips 
(around 15–20mm field of view). Although the clip-on lens 
could not be used with the toy camera, the benefits of macro 
lens addition for closer focus was clear for both the budget 
smartphone and toy camera, and it was possible to quantify 
absorbance within 200 µm diameter microfluidic channels 
with both of these very low cost cameras- in spite of their low 
quality image sensor and optics. Whilst the addition of macro 
lens made it possible to resolve individual microcapillaries 
and quantify colorimetric assays (Figure 2B), there was a 
significant trade-off as closer focusing gave a smaller field of 
view and significantly reduced the number of microfluidic devices 
that could be simultaneously recorded.
In conclusion, the camera type significantly influenced the 
number of microfluidic devices that could be recorded 
simultaneously, with the lower the quality of optics and 
digital sensor, the fewer the microdevice measurements that can 
be captured in one single image. However, as long as the camera 
was able to resolve individual microchannels, dye quantitation 
was possible. All original image files are shared through the 
experimental dataset accompanying this paper.
Performance differences and quantitation. Having estab-
lished that multiple microcapillary devices could be imaged, 
with some resolution limitations for the lower quality cam-
eras, colorimetric absorbance was quantified and plotted 
against concentration to determine the relative analytical per-
formance of different cameras (Figure 3). With the lower 
resolution images, every effort was made to record the intensity 
for each capillary where the test strip was clearly visible. 
However, in many strips capillaries with lower concentrations 
could not be distinguished and no intensity could be measured, 
and so data points were only recorded when the intensity value 
for individual capillaries could be clearly identified after 
plotting intensity profiles on ImageJ. Comparing camera 
phones and smartphones showed that the whole range of phone 
cameras tested were capable of recording and quantifying 
colorimetric dye in microfluidic devices (Figure 3A). However, 
the entry-level smartphone plus two feature phones – mobile 
phones with simple cameras but without touchscreens and with 
simple button interface – required the macro lens to resolve 
individual capillaries and permit quantitation. This reduced 
the number of test strips that could be imaged simultaneously. 
With both entry-level and mid-range smartphones 14 devices 
each containing 10 microcapillaries were imaged (i.e. 140 data 
points), in contrast after adding the macro lens to the three 
lower-quality camera phones for closer focus reduced this to 
recording 4 or fewer devices measuring only 40 capillaries 
i.e. 3.5x less data per image.
Surprisingly, the better optics and larger sensor in the three 
digital cameras did not appear to improve colorimetric 
quantitation, and both compact digital cameras (Powershot 
S120 and Ricoh WG4) and the DSLR showed very limited 
difference in absorbance between the 140 µM and 32 µM 
concentrations, whereas all phone cameras showed a large 
absorbance change over this range. When equipped with a 
macro lens to focus closely, the toy camera also showed a 
clear difference in absorbance between these concentrations 
(Figure 3A, B). The largest sensor and best optics found in 
the DSLR with macro lens did allow capillaries to be clearly 
identified with dye concentration as low as 1.3 µM and 
there was a clear increase in absorbance across the 1.3 µM to 
140 µM range with this camera, but given the absorbance only 
increased 2-fold over this >100-fold increase in concentration, 
the gradient is barely steep enough for accurate quantitation. 
Thus, although colorimetric detection is clearly feasible with a 
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Figure 2. Example images of colorimetric microfluidic assays taken with range of digital cameras and phones. A series of five 
5-fold concentrations of diaminophenazine dye (DAP) dye was made, representing the colorimetric product of horseradish peroxidase 
enzyme substrate conversion used in conventional enzyme immunoassays. These simulated immunoassay samples, plus a negative control, 
were loaded into pairs microcapillary film test strips. The full set of 12 samples were imaged using a range of different digital cameras, plus a 
laboratory gel scanner and consumer A4 flatbed scanner. A) example images illustrating the image quality are shown, with the blue channel 
where maximal absorbance of DAP presented. The distance of the camera to the sample to achieve an appropriate field of view is indicated 
in cm. B) Two examples of lower quality cameras, where individual capillaries could not be resolved when imaging the full set of 12 samples, 
so an additional macro lens was added allowing closer focus that permitted dye concentration to be quantified.
wide range of digital cameras, with high resolution optics and 
larger sensors permitting capture of many devices, or lower 
quality digital imaging able to capture fewer devices, there 
may be limits to both analytical sensitivity and to measurable 
dynamic range. However, the dynamic range can be increased 
by varying camera settings such as exposure times and sensor 
sensitivity (Figure 1D).
Finally, an industrial machine vision camera, a flatbed scanner, 
and a laboratory gel scanner were compared, none of which 
offered improved quantitation over the phone cameras or digital 
cameras (Figure 3C). The industrial machine vision camera 
required the macro lens for closer focus and was only able to 
capture 4 devices per image, in contrast the flatbed scanner was 
capable of capturing very large numbers of devices, with at least 
150 devices (each with 10 capillaries, i.e. 1500 microchannels) 
fitting on a single scan. It is possible with further optimisation 
of imaging or scanning conditions, these digital imaging devices 
would meet the performance of the digital cameras, however 
this demonstrates that consumer digital cameras are more than 
capable of recording quantitative bioassay readouts alongside 
industrial/laboratory devices.
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Figure 3. Quantitation of colorimetric bioassay signal by different digital cameras. Absorbance was calculated for the images in 
Figure 2 from the reduction in blue channel intensity for each individual capillary. The mean absorbance for 10 individual capillaries was 
then plotted against concentration, to illustrate the relative analytical performance for microfluidic colorimetric bioassay measurement by 
a range of digital cameras. A) Comparison of feature phones vs smartphones; where indicated a macro lens was used to be able to resolve 
individual capillaries. B) Comparison of consumer digital cameras. C) Comparison of industrial camera vs laboratory scanners vs consumer 
flatbed scanner. Error bars indicate the standard deviation of 10 capillaries. Lower absorbance values are plotted (Right) with smaller y-axis 
range to permit comparison of detection of limiting concentrations of fluorophore.
Comparison of camera performance for digital imaging 
of fluorometric microfluidic tests
Fluorescent readouts can offer higher analytical sensitivity 
than colorimetric detection, although sensitivity of fluorescent 
detection depends significantly on excitation intensity and 
wavelength, quality of emission filters, in addition to the 
optical detector used. We found that even with the very simple 
and low-cost fluorescence imaging setup comprising an open 
source blue LED array transillumination device plus a simple 
amber acrylic emission screen, significantly lower concentra-
tions of fluorescein were measurable – with some cameras clearly 
detecting 0.5 µM and lower – than with the colorimetric dye 
where the lowest measurable concentration was 10 µM or higher 
(Figure 1D, Figure 4).
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As with the colorimetric measurements, images with a wide 
range of cameras are compared in Figure 4, with the working 
distance needed to capture the full set of devices indicated. 
Although all cameras clearly recorded the changes in concentration 
between test strips, for many images the individual capillaries 
could not be resolved. As with colorimetric measurements, the 
macro lens allowed closer focussing and thereby facilitated 
quantitation of fluorescence within individual capillaries 
for the lower quality cameras, with even the cheapest toy 
camera capable of recording individual capillary intensity. All 
original image files are shared through the experimental dataset 
accompanying this paper26.
The least effective fluorescence detection within the group of 
phone cameras was with the two feature phones (Alcatel and 
CAT B30), which although equipping with the macro lens for 
closer focussing permitted individual capillaries to be clearly 
resolved, very limited difference in intensity was measured 
across a wide range of fluorescein dye (Figure 5A). In contrast, 
the budget smartphone (Alba Phone) gave adequate quantitation 
Figure 4. Example images of fluorescent microfluidic readout taken with a range of digital cameras and phones. A series of 5-
fold dilutions of fluorescein were made to represent a range of results of fluorescent bioassays. A panel of microcapillary film strips filled 
with these fluorescein samples were imaged in parallel using the indicated range of cameras and lab scanners. A) example images for 
these cameras, with the distance from camera to sample to image the full sample set indicated in cm. B) For two cameras unable to resolve 
individual microcapillaries when imaging the full set of samples, macro lenses were added to allow closer focusing, with example images 
illustrating the improved resolution of macro images, and mean fluorescence of 10 replicate capillaries plotted to show how quantification 
of fluorescein remains possible even with these lowest performance cameras.
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Figure 5. Quantitation of fluorescent microfluidic readout with a range of digital cameras and phones. The signal intensity 
for the images in Figure 4 were determined and mean fluorescence intensity for 10 individual capillaries plotted against concentration. 
A) Comparison of feature phones vs smartphones; where indicated a macro lens was used to be able to resolve individual capillaries. 
B) Comparison of consumer digital cameras. C) Comparison of industrial camera vs two laboratory fluorescent scanners. Error bars indicate 
the standard deviation of 10 capillaries. Lower intensity values are plotted (Right) with smaller y-axis range to permit comparison of detection 
of limiting concentrations of fluorophore.
of fluorescence with the macro lens. This difference could be 
influenced not only by the sensor and lens, but also possibly by 
the image acquisition software. The budget smartphone has a far 
bigger screen and far better processing power onboard than 
the two feature phones, that may permit improved imaging of 
fluorescence within microfluidic devices. However, the higher 
performance smartphones (iPhone 4S and iPhone 6S) were 
clearly superior at quantitation of fluorescent microfluidic 
devices, showing clear quantitation below 0.2 µM and 0.5 µM 
respectively. The digital cameras were all far better at quantitation 
of fluorescence than colorimetric dye, with the two compact 
digital cameras performing similarly to the DSLR and all 
capable of measuring 0.2 µM fluorescein (Figure 5B). However, 
the higher concentrations of fluorescein were saturated for 
two of the digital cameras, suggesting that careful utilisation 
of what are typically 8-bit intensities (i.e. 256 shades) is needed 
to maximise assay dynamic range. Even the cheapest toy 
camera was capable of adequate quantitation, although at far 
higher concentrations – with the first steep rise in intensity 
visible from 2 µM up to 8 µM fluorescein – and requiring the 
macro lens for close focussing. Again, the industrial machine 
vision camera gave less sensitive detection of fluorescence than 
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many of the consumer digital cameras and phone cameras, 
and the macro lens was essential for close focussing to resolve 
individual capillaries. The two laboratory scanners, designed 
for scanning fluorescence, proved no better at quantitation of 
fluorescence within microfluidic devices than the consumer 
digital cameras (Figure 5C).
Antiviral antibody levels can be measured using a wide 
range of smartphones, cameras or laboratory imaging 
systems
Anti-viral antibody measurement assays were selected to 
illustrate fluorometric bioassays where microfluidic point-of-care 
and testing outside a lab could be valuable, especially in 
resource limited regions where use of low-cost consumer 
digital cameras is of greatest benefit. We wanted to demonstrate 
the quantitation of bioassays was largely unaffected by camera 
type, and we therefore made use of recombinant positive 
control antibodies spiked into negative control plasma to 
provide uniform assays. Indirect immunoassays with multiple 
patient sample dilution are typically used to quantify levels of 
antibody against viral antigens, for example for serosurveil-
lance programs. Although we published proof-of-concept of 
indirect immunoassays using mouse antibodies, here we used 
recombinant humanised monoclonal antibodies spiked into 
human plasma. Microcapillary film strips internally coated 
with DENV2 E protein or SARS-CoV-2 S protein were used to 
measure reactivity at multiple dilutions of simulated plasma 
samples, and after assay was completed were imaged using 
the indicated cameras. With all cameras, all response curves 
showed the expected dilution-intensity relationship (Figure 6), 
with both IgM assays only showing weak signal at the lower 
dilutions (1:20 and 1:60) vs the far higher signal that is 
maintained after multiple serial dilutions for the spiked 
positive control samples. For anti-DENV IgG the background 
was somewhat higher at these lower dilutions for control 
samples, as expected given the higher levels of IgG found in 
plasma, but the spiked positive control still showed far higher 
signals when more highly diluted. Both the stand-alone camera 
module and a laboratory scanner showed similar performance 
to the consumer digital cameras, with a Raspberry Pi 3 B + 
connected to the 8MP camera module v2, representing an open 
source and lower cost version of the IDS industrial machine 
vision camera.
Each set of dilutions represented 8 test strips, each with 10 rep-
licate capillaries, hence each individual image captured 80 data 
points. For this comparison of cameras with immunoassays, 
the full set of test strips were imaged in one single image, but 
for the lowest resolution camera (the toy camera) it was not 
possible to distinguish clearly distinct capillaries (see Figure 1B 
for examples), yet clear differences in intensity were measured 
for the whole strip.
All the imaging systems gave similar response curves with 
exception of the toy camera, which showed reduced signal for 
the strong positive control in the IgG assay. Furthermore, the 
low-quality image with the toy camera made it hard to distin-
guish individual capillaries, so multiplex analysis would not 
be feasible with distinct bioassays in each of the 10 capillaries. 
Thus although the lowest performance (and cheapest) camera 
was still capable of quantifying overall fluorescent intensity 
and thus capably of quantifying microfluidic immunoassay 
results, the reduced analytical performance combined with an 
inability to capture as many test strips in a single photo makes it 
less suitable to quantitative clinical measurements. We conclude 
that a very wide range of digital imaging devices including 
smartphones, feature phones, consumer digital camera, and 
camera modules are all effective at recording clinically impor-
tant immunoassays in microfluidic devices. Higher resolu-
tion digital imaging can offer higher density of data capture. All 
original image files are shared through the experimental dataset 
accompanying this paper.
Critical parameters for successful digital imaging of 
microfluidic devices
We suggest the following framework for selecting a camera for 
digital imaging of microdevices and bioassays. Firstly, establish 
the clinical need and analytical requirements (i.e. measurement 
range, limit of detection) and thereby define the number and 
size of devices that need to be recorded. Alongside this, it is 
important to understand any regulatory constraints such as any 
need to have complete control over software or camera settings. 
Whilst separate from the technical requirements evaluated in this 
study, such regulatory or software requirements may rule-out 
use of consumer products. Once the number and size of devices 
are defined, both the overall image size needed (camera field of 
view) and the resolution required to quantify individual test 
areas can be established. As far as we could establish in this 
study, as long as the image acquired can resolve individual 
microdevice channels i.e. each analytical chamber can be 
clearly identified on the final image, the camera will be able to 
quantify signal. We do suggest real-world images are taken to 
establish image resolution however, as the observed resolution 
may not match manufacturers claimed performance. The 
working distance from camera to devices may also influence 
setup. Finally, the dynamic range of quantitation of signal, and 
analytical sensitivity required must both be considered. It may 
be necessary to modify camera settings to expand dynamic range 
or to match the required analytical sensitivity.
Conclusion
We found that a wide range of digital cameras – including the 
lowest cost consumer products – were capable of recording 
and quantifying fluorescence and colorimetric signal in 200 µm 
diameter channels within microfluidic devices. Nevertheless, 
there are clear benefits of higher performance optoelectronics 
modules, both in terms of sensitivity and quantitation of lower 
concentrations of target signal, and in number of microfluidic 
channels that can be simultaneously captured. Likewise, camera 
optics had some influence on detection, but even addition of a 
very simple macro lens was sufficient to allow low resolution 
digital cameras to capture and quantify microfluidic device 
signal. With the higher performance cameras, a higher resolu-
tion image made it easier to resolve individual microfluidic 
channels, and allowed simultaneous capture of larger numbers 
of microdevices. Finally, we found that that most digital 
cameras including budget smartphones are very capable of 
capturing and quantifying fluorescent microfluidic immunoassays 
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Figure 6. Comparison of a wide range of digital cameras for recording microfluidic immunoassays to measure antiviral antibody. 
Three simulated patient samples were made by spiking two different levels of recombinant antiviral antibodies into human serum, plus a 
negative control. Simulated IgM anti-dengue (Left), recombinant IgG anti-dengue (Middle) and recombinant IgM anti-SARS-CoV2 samples 
were serially diluted and 7 dilutions plus one blank (no serum) tested in microcapillary film (MCF) test strips coated with the respective 
viral protein, followed measuring human antibody level by enzyme fluorescence. The same set of 8 samples were imaged by the indicated 
cameras or scanner, and mean fluorescence intensity for 10 individual capillaries plotted; error bars indicated the standard deviation of 10 
capillaries. These data are representative of three or more independent assays and camera comparisons.
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to measure antibody responses to two viral infections of global 
health significance: dengue fever and COVID-19. Overall, this 
study highlights the range of performance requirements for 
digital capture of miniature diagnostic tests, and provides a 
framework to develop a clear specification combining the 
clinical diagnostic application with the device type, to permit 




Figshare: Dataset associated with the article “Affordable 
mobile microfluidic diagnostics: minimum requirements for 
smartphones and digital imaging for colorimetric and fluoro-
metric viral antibody detection”. https://doi.org/10.6084/
m9.figshare.1310341426.
This project contains the following underlying data:
-     Images and list of imaging systems and conditions.
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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